Advertisement
Abstract| Volume 92, SUPPLEMENT 1, S19, March 2018

Proof of concept and mode of action of a novel modular platform for adoptive T cell therapy combining bispecific antibodies with synthetic agonistic receptors

DOI:https://doi.org/10.1016/j.ejca.2018.01.047
Proof of concept and mode of action of a novel modular platform for adoptive T cell therapy combining bispecific antibodies with synthetic agonistic receptors
Previous ArticleEliciting protective T cell immunity against EBV-associated malignancies by vaccination
Next ArticleMesothelin-targeted bispecific antibodies drive synthetic agonistic receptor – Transduced T cells to mediate specific and conditional therapy of human pancreatic cancer models
      Background: In adoptive T cell therapy (ACT), one of the greatest challenges is the recruitment of T cells to tumor tissue. T cells, engineered with chimeric antigen receptors (CAR) haven proven efficacy for hematological malignancies but at the same time induce severe side effects such as cytokine release syndrome. We herein describe a novel MHC-unrestricted modular platform by combining autologous T cells, transduced with a targetable synthetic agonistic receptor (SAR), with crosslinking bispecific antibodies (BiAb) that specifically recruit and activate T cells to the tumor tissue.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      Article info

      Publication history

      P07. Adoptive cell therapy P07.01

      Identification

      DOI: https://doi.org/10.1016/j.ejca.2018.01.047

      Copyright

      © 2018 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX